2. About Us
Who We Are

Supplying Essential Medicines Globally

Established in 2021, Mednine Global is a specialized pharmaceutical supplier committed to delivering high-quality medicines to hospitals, clinics, pharmacies, wholesalers, importers, NGOs, UN agencies, and government-supported healthcare institutions.

With its headquarters in India and an expanding operational presence across South Sudan, the Central African Republic, Sierra Leone, Liberia, and Afghanistan, the company plays a pivotal role in enhancing access to safe, effective, and affordable healthcare solutions in underserved market.

Mednine Global is supported by a strong workforce of over 100 professionals representing diverse cultures and backgrounds. This collective expertise enables the organization to understand varied client requirements and deliver solutions that are aligned with operational realities, regulatory expectations, and on-ground healthcare needs.

The company’s growth is built on accountability, performance, and trust. Mednine Global places responsibility at the core of every engagement, striving to consistently deliver high standards of service while upholding integrity, respect, and long-term commitment in all relationships.

Mr Malay Mehta

Mr. Malay Mehta

Founder & Director

Malay Mehta is the Founder and Director of Mednine Global, leading the company’s vision and global expansion in the pharmaceutical sector. He earned his Bachelor of Pharmacy (B.Pharm) in 2007 from Dr. M.G.R. Medical University, Chennai. Under his leadership, Mednine Global has established branches across four countries, strengthening its international footprint. Driven by a commitment to quality, innovation, and accessible healthcare, he continues to guide the company toward becoming a trusted global pharma brand.

Mr Rajesh Dewani

Mr. Rajesh Dewani

Director

Mr. Rajesh Dewani is the Director, Principal Advisor, and Shareholder of Mednine Global. He earned his Post Graduate Diploma in International Trade in 1994 from Symbiosis, Pune. Since then, he has been actively engaged in business across multiple continents and diverse sectors, including EPC Construction, Trading, and Procurement Services. With his extensive global exposure and deep trade expertise, Mr. Dewani plays a pivotal role in guiding Mednine Global’s strategic direction and inspiring growth-driven leadership across the organization.

Vision

To emerge as a globally respected pharmaceutical enterprise, enhancing quality of life across regions by delivering innovative, reliable, and accessible healthcare solutions that contribute to a healthier and more sustainable future for communities worldwide.

Mission

To develop and deliver safe, effective, and affordable pharmaceutical products that meet global standards, while expanding access to quality healthcare through innovation, operational excellence, ethical practices, and strong partnerships across international markets.

Core Values

Guided by patient-focused care, uncompromising quality, integrity, innovation, global responsibility, and collaborative partnerships, we remain committed to delivering healthcare solutions with precision, accountability, and lasting positive impact.

Our Journey

Growth Over the Years

Tracing the path of our expansion and the milestones that define our progress and purpose.

2026
Afghanistan (Upcoming)

Golden Healthcare’s entry into the Afghanistan market marks a key milestone in strengthening our international footprint.

2026
Liberia

Golden Relief Pharma’s entry into the Liberian market marks the beginning of operations and regional expansion in West Africa.

2025
Sierra Leone

Golden Life Care Pharma (SL) Limited was established, quickly building a strong and trusted client base.

2024
Central African Republic

Relief Pharma SARL was established to expand operations in Central African Republic and improve regional healthcare access.

2023
South Sudan

Expansion with the establishment of a second branch, strengthening operations, and market presence.

2021
South Sudan

Golden Pharma Ltd. was established, marking the foundation of the company’s pharmaceutical journey.

5+
Countries Served
100+
Team Members
300+
Our Segments
2000+
Partner Institutions